Board Of Trustees Of The Leland Stanford Junior University Logic Bio Therapeutics, Inc. Transaction History

Board Of Trustees Of The Leland Stanford Junior University

  • $1.17 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020
SELL
$4.06 - $11.0 $2.99 Million - $8.11 Million
-736,827 Closed
0 $0
Q4 2019

Feb 12, 2020
SELL
$7.01 - $11.01 $1.49 Million - $2.34 Million
-212,616 Reduced 22.39%
736,827 $5.31 Million
Q2 2019

Aug 12, 2019
BUY
$9.77 - $17.08 $392,744 - $686,598
40,199 Added 4.42%
949,443 $12.3 Million
Q4 2018

Feb 12, 2019
BUY
$7.88 - $17.98 $7.16 Million - $16.3 Million
909,244 New
909,244 $9.46 Million

About LogicBio Therapeutics, Inc.

LOGC Quotes by TradingView
  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track Board Of Trustees Of The Leland Stanford Junior University Portfolio

Follow Board Of Trustees Of The Leland Stanford Junior University and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Board Of Trustees Of The Leland Stanford Junior University, based on Form 13F filings with the SEC.

News

Stay updated on Board Of Trustees Of The Leland Stanford Junior University with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email